| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 24,716 | 91,418 | 16,789 | 50,077 | | Cost of Revenue | 23,145 | 38,850 | 19,793 | 40,416 | | | Gross Profit | 1,571 | 52,568 | (3,004) | 9,661 | | | Operating Expenses | | Research Development | 4,826 | 7,187 | 3,930 | 5,438 | | Selling General and Administrative | 5,370 | 6,029 | 6,668 | 5,994 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 481 | 325 | 344 | 328 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (9,106) | 39,027 | (13,946) | (2,099) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 21 | (72) | 76 | 166 | | Earnings Before Interest And Taxes | (9,085) | 38,955 | (13,870) | (1,933) | | Interest Expense | 3,120 | 2,821 | 2,722 | 2,387 | | Income Before Tax | (12,205) | 36,134 | (16,592) | (4,320) | | Income Tax Expense | 43 | 4 |
-
| 14 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (12,248) | 36,130 | (16,592) | (4,334) | | | Non-recurring Events | | Discontinued Operations | 5 | 2 | 54 | 11 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (12,243) | 36,132 | (16,538) | (4,323) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($12,243) | $36,132 | ($16,538) | ($4,323) |
|
0.02% Nasdaq 
Income Statement
